Aggressive course of atherosclerosis in hyperlipoproteinemia (a): a case series

Aggressive course of atherosclerosis in hyperlipoproteinemia (a): a case series

Currently, worldwide interest in lipoprotein(a) (LP(a) as one of the most important markers of premature and aggressive atherosclerosis is steadily growing. This trend is due to both the new data on the pathogenesis of hyperlipoproteinemia (a) and the development of novel treatment methods in the ne...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. M. Namitokov, V. K, Zaphiraki, E. K. Donets, O. B. Malyarevskaya, K. V. Karabakhtsieva, A. N. Yahutl
Format:	Article
Language:	English
Published:	Столичная издательская компания 2023-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	hyperlipoproteinemia (a) atherosclerosis myocardial infarction lipoprotein(a) revascularization
Online Access:	https://www.rpcardio.online/jour/article/view/2873
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment
by: A. M. Namitokov, et al.
Published: (2025-04-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

Efficacy and safety of tafolecimab a new PCSK9 inhibitor in patients with hyperlipidemia: a systematic review and meta-analysis of randomized controlled trials
by: Ali Ashraf Salah Ahmed, et al.
Published: (2025-06-01)

Lipoprotein(a) in the diagnosis of cardiovascular risk. The values of lipoprotein (a) and apolipoprotein B in the adult population of Krasnoyarsk
by: V. S. Emelyanchik, et al.
Published: (2023-08-01)

Molecular dynamics of select missense mutations of Apolipoprotein E and their implications in Hyperlipoproteinemia type III
by: Sumit Thakur, et al.
Published: (2025-09-01)

Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases
by: O. I. Afanasieva, et al.
Published: (2019-06-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Myocardial ischemia on the background of paroxysmal atrial fibrillation: result of arrhythmia or sign of coronary atherosclerosis?
by: I. S. Metelev, et al.
Published: (2021-06-01)

Prevalence of familial hypercholesterolemia and hyperlipoproteinemia(a) in patients with premature acute coronary syndrome
by: U. V. Chubykina, et al.
Published: (2022-07-01)

ASSOCIATION OF ELECTROCARDIOGRAPHIC MARKERS OF METABOLIC CARDIOMYOPATHY WITH LONG-TERM RESULTS OF MYOCARDIAL REVASCULARIZATION IN MEN WITH CORONARY ATHEROSCLEROSIS
by: N. A. Timoshenko, et al.
Published: (2014-06-01)

Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women
by: O. I. Afanasyeva, et al.
Published: (2010-12-01)

The relationship of arterial hypertension, elevated low-density lipoprotein cholesterol and their combination with the occurrence of new cases of cardiovascular diseases in men and women of working age
by: S. A. Shalnova, et al.
Published: (2024-06-01)

Relationship between the white blood cell count and some lipid profile parameters in cancer patients with myocardial infarction
by: E. G. Skorodumova, et al.
Published: (2024-08-01)

Relationship between vascular age and atherosclerosis-related cardiovascular diseases
by: R. N. Najafov
Published: (2021-07-01)

Lipoprotein(a) and Blood Monocytes as Factors for Progression of Carotid Atherosclerosis in Patients with Premature Coronary Heart Disease
by: Alexandra V. Tyurina, et al.
Published: (2025-06-01)

N-TERMINAL BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2012-06-01)

Prospects of Using PCSK9 Inhibitors for Acute Coronary Syndrome
by: A. M. Namitokov, et al.
Published: (2024-04-01)

Variety of clinical manifestations of hypertriglyceridemia: a case series
by: V. K. Zafiraki, et al.
Published: (2023-09-01)

Sex Differences in the Association Between Lipoprotein(a) and Cardiovascular Outcomes: The MGB Lp(a) Registry
by: Gurleen Kaur, et al.
Published: (2025-05-01)

Effects of photochemotherapy on cardiometabolic markers in Eastern patients with psoriasis, with and without atherosclerosis: a pilot comparative study
by: Heba Moftah, et al.
Published: (2025-05-01)

Lipoprotein(a) as a factor in the severity of vascular events in patients with ischemic stroke, stage 3 hypertension and multifocal atherosclerosis
by: S. S. Vedenskaya, et al.
Published: (2025-03-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Severe hyperlipoproteinemia(a) as a factor of rapidly progressive coronary artery disease in a young woman with heterozygous familial hypercholesterolemia
by: U. V. Chubykina, et al.
Published: (2019-06-01)

Lipoprotein(a), atherosclerosis and cardiovascular risk
by: E. A. Polyakova, et al.
Published: (2024-12-01)

The Relationship between Lipoprotein A and the Prevalence of Multivessel Coronary Artery Disease in Young Patients with Acute Myocardial Infarction: An Observational Study
by: Ionut Cezar Buciu, et al.
Published: (2024-09-01)

Role of Cathelicidins in Atherosclerosis and Associated Cardiovascular Diseases
by: Siarhei A. Dabravolski, et al.
Published: (2024-08-01)

Carbohydrate and lipid metabolism indices dynamic in patients with postinfarction cardiosclerosis, type 2 diabetes and obesity in 6 months and 1 year after myocardial revascularization
by: P. P. Kravchun
Published: (2016-11-01)

Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
by: Mei Dong, et al.
Published: (2025-01-01)

Role of blood cholesterol transport system disturbances in atherosclerosis development in rheumatoid arthritis
by: T. V. Popkova, et al.
Published: (2007-10-01)

The era of targeted therapy for hyperlipidemia
by: U. V. Chubykina, et al.
Published: (2024-10-01)

The level of endogenous testosterone and its correlation with lipid profile in men older than 40 years with acute myocardial infarction
by: Barać Branko, et al.
Published: (2020-01-01)

Fractional flow reserve-guided complete vs. culprit-only revascularization in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis
by: Jingxian Yang, et al.
Published: (2025-03-01)

VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY
by: E. P. Trukhacheva, et al.
Published: (2016-01-01)

Emerging Biomarkers in Atherosclerosis: Advancing Early Detection and Risk Stratification
by: Aleksandra Sojka, et al.
Published: (2024-12-01)

ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE
by: A. I. Chesnikova, et al.
Published: (2015-12-01)

Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study
by: Francesco Gianfagna, et al.
Published: (2025-07-01)

The Association of Lipoprotein(a) with Major Adverse Cardiovascular Events after Acute Myocardial Infarction: A Meta-Analysis of Cohort Studies
by: Huiruo Liu, et al.
Published: (2025-05-01)

Exploring the Relationship Between Lipoprotein (a) Level and Myocardial Infarction Risk: An Observational Study
by: Ionut Cezar Buciu, et al.
Published: (2024-11-01)

Lipoprotein transport and metabolism markers in patients with myocardial infarction in the Biobank of Yugra blood sample collection
by: A. S. Vorobyov, et al.
Published: (2025-01-01)

Distant myocardial infarction: a case report
by: K. G. Pereverzeva, et al.
Published: (2023-12-01)